S104 THE BRAF INHIBITOR VEMURAFENIB COMBINED WITH RITUXIMAB PRODUCES A HIGH RATE OF DEEP AND DURABLE REMISSIONS IN RELAPSED OR REFRACTORY HAIRY CELL LEUKEMIA: UPDATED RESULTS OF A PHASE-2 TRIAL
| Autor: | Samantha Ferrari, Enrico Tiacci, Natalia Frattarelli, L. De Carolis, Brunangelo Falini, Monia Capponi, Paolo Falcucci, R. Della Seta, Eugenio Lucia, A. Ambrosetti, Giuseppe Visani, G. Gaidano, Edoardo Simonetti, Alessandro Pulsoni, Robert Foa, Francesco Zaja, L. Rigacci, Agostino Antolino, P. L. Zinzani |
|---|---|
| Rok vydání: | 2019 |
| Předmět: | |
| Zdroj: | HemaSphere. 3:3 |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.hs9.0000558636.55215.ad |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text